{"nct_id":"NCT01604343","title":"A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)","status":"COMPLETED","status_verified_date":"2017-12","start_date":"2012-08-15","start_date_type":"ACTUAL","primary_completion_date":"2015-09-02","primary_completion_date_type":"ACTUAL","completion_date":"2016-12-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}